Trials Annotator

Org. Study IDs: CAPPA-2
Secondary IDs: 2005-005631-97

Last trial update was posted on 2017-03-28

Gemcitabine

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Non-Small Cell Lung Cancer

scarce enrolment and presentation of positive results of similar study in June 2012.

N/A

Morabito A, Gebbia V, Di Maio M, Cinieri S, Vigano MG, Bianco R, Barbera S, Cavanna L, De Marinis F, Montesarchio V, Costanzo R, Sandomenico C, Montanino A, Mancuso G, Russo P, Nacci A, Giordano P, Daniele G, Piccirillo MC, Rocco G, Gridelli C, Gallo C, Perrone F. Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study. Lung Cancer. 2013 Jul;81(1):77-83. doi: 10.1016/j.lungcan.2013.04.008. Epub 2013 May 1. [PMID: 23643177] [DOI: 10.1016/j.lungcan.2013.04.008]

No annotators decided on categories yet

#	Outdated	Intervention				Condition
#	Outdated	Name		Route	DrugBank ID	Condition